RAFAEL HOLDINGS, INC. Realized Investment Gains (Losses)
RAFAEL HOLDINGS, INC. (RFL) reported Realized Investment Gains (Losses) of $2.00 thousand for the 6-month period ending 2025-01-31, per its 10-Q filed 2025-03-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2025-12-12
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for the quarter ending 2025-01-31 was $196.00K.
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for the quarter ending 2024-10-31 was -$194.00K.
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for the quarter ending 2024-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for the quarter ending 2024-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for fiscal 2024 was -$46.00K, a 114.89% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. realized investment gains (losses) for fiscal 2023 was $309.00K.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 3 month as first filed | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|---|
| 2025-01-31 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | $2.00K 10-Q · filed 2025-03-14 | $2.00K derived: sum of 3 quarters · filed 2025-12-12 | $2.00K derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-10-31 | -$194.00K 10-Q · filed 2025-12-12 | $2.00K 10-Q · filed 2024-12-11 | -$194.00K derived: sum of 2 quarters · filed 2025-12-12 | -$194.00K derived: sum of 3 quarters · filed 2025-12-12 | -$194.00K derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $0.00 derived: sum of 3 quarters · filed 2025-10-29 | -$46.00K 10-K · filed 2025-10-29 | |
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $0.00 derived: sum of 2 quarters · filed 2025-06-11 | -$46.00K 10-Q · filed 2025-06-11 | ||
| 2024-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$46.00K 10-Q · filed 2024-03-14 | |||
| 2023-10-31 | -$46.00K 10-Q · filed 2023-12-14 | ||||
| 2023-07-31 | $309.00K 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |